All View

Product Information
Registration Number DR-XY 47870
Generic Name Acalabrutinib
Brand Name Calquence
Dosage Strength 100 mg
Dosage Form Capsule
Classification Prescription Drug (RX)
Packaging Alu/Alu Blister Pack x 8's (Box of 56's)
Pharmacologic Category Antineoplastic agent (Protein Kinase Inhibitor)
Manufacturer AstraZeneca AB
Country of Origin Sweden
Trader N/A
Importer AstraZeneca Pharmaceuticals (Phils.), Inc.
Distributor N/A
Application Type Monitored Release
Issuance Date 30 March 2022
Expiry Date 30 March 2027